|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
In the Spotlight April 2004
pharmaceutical science and technology innovations
Articles in this issue
over 21 years ago
Spotlight on Business Riskover 21 years ago
Vibration Technology for Active Dry-Powder Inhalersover 21 years ago
FDA Attacks Counterfeitsover 21 years ago
Synthetic Excipients Challenge All-Natural Organicsover 21 years ago
April 2004over 21 years ago
Controlled-Release Dosage Forms for Diltiazem HydrochlorideNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Audits, Inspections, and CDMOs
2
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
3
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
4
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
5
